Search


	Podcast:		OncLive® On Air
	Episode:		37: Tolaney Talks Tailored Treatment Strategies in HER2+ Breast Cancer
	Category:		Science & Medicine
	Duration:		00:16:10
	Publish Date:		2020-09-10 19:20:53
	Description:		In our exclusive interview, Sara M. Tolaney, MD, MPH, shared insight on how risk status is being used to tailor HER2-directed therapies to patients with early-stage HER2-positive breast cancer, key trials focused on delineating optimal deescalated and escalated treatment strategies, and ongoing research in the HER2-low setting.
	Total Play:		0